TrialJournal of neuro-oncology2021
MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma.
Matthijs van der Meulen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papertrialcites it